Coronavirus (COVID-19) Q&A Podcast
1) Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections
Interview with Robert Bals, MD, PhD, author of Azelastine Nasal Spray for Prevention of SARS-CoV-2 Infections: A Phase 2 Randomized Clinical Trial, and Dan H. Barouch, MD, PhD, author of A Novel Appro...Show More
2) Association of New-Onset Seizures With SARS-CoV-2 Vaccines
Interview with Churl-Su Kwon, MD, MPH, author of Association of New-Onset Seizures With SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Hosted by Cynthia E. A...Show More
3) Measuring Medicaid Enrollment More Accurately to Guide Post–COVID-19 Pandemic Policy
Benjamin D. Sommers, MD, PhD, of Harvard University, speaks with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, about differences in Medicaid enrollment as meas...Show More
4) February 2024 Medical News Summary
Rural Maternity Care Is in Crisis—Here’s What Could Help; Type and Severity of Immunodeficiency Affect Speed of SARS-CoV-2 Clearance, Study Finds Related Content: More Than Half of US Rural Hospital...Show More
5) Evaluating the Effectiveness of Bivalent COVID-19 Vaccines in Children and Adolescents
Bivalent mRNA COVID-19 vaccines were recommended for children and adolescents aged 5 to 17 years in the US, but were they effective? JAMA Associate Editor Tracy A. Lieu, MD, MPH, spoke with author Leo...Show More
6) Changes in Access to Care and Preventive Services by Race and Ethnicity During the COVID-19 Pandemic
The COVID-19 pandemic has caused major disruptions in ambulatory care. In this interview with JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, Rishi K. Wadhera, M...Show More
7) Safety and Effectiveness of Maternal and Child COVID-19 Vaccination
Two recent studies find that COVID-19 vaccination during pregnancy is safe for infants and effective for children aged 1-4 years. JAMA Pediatrics Editor in Chief Dimitri Christakis, MD, and JAMA Pedia...Show More
8) The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children
During the COVID-19 pandemic, the incidence of diabetes in childhood increased. JAMA Associate Editor Anne R. Cappola, MD, ScM, and Ezio Bonifacio, PhD, from the Center for Regenerative Therapies at t...Show More
The Connection Between SARS-CoV-2 and Type 1 Diabetes Risk in Young Children
14:45 | Sep 26th, 2023
9) Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction
Interview with Jay F. Piccirillo, MD, author of Efficacy of Gabapentin For Post–COVID-19 Olfactory Dysfunction: The GRACE Randomized Clinical Trial. Hosted by Paul C. Bryson, MD, MBA. Related Content...Show More
10) Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy
In this interview, JAMA Health Forum Editor John Ayanian, MD, MPP, and Deputy Editor Melinda Buntin, PhD, explore with Erin K. McCreary, PharmD, and Atheendar S. Venkataramani, MD, PhD, how a large re...Show More
Innovative Approach to Promote Equitable Access to COVID-19 Preventive Therapy
21:45 | Sep 1st, 2023